ArticleBiomedicines2023

Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines.

Xuemei Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.